SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER

Clinical trials for SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER explained in plain language.

Never miss a new study

Get alerted when new SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER trials appear

Sign up with your email to follow new studies for SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New heart valve offers hope for patients with severe leaky heart

Disease control Not yet recruiting

This early study tests a new device called the TRICENTO G2 to treat severe tricuspid regurgitation, a condition where a heart valve leaks badly. Ten adults with symptoms like shortness of breath or swelling will get the valve through a minimally invasive procedure. The goal is to…

Matched conditions: SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER

Phase: NA • Sponsor: Medira GmbH • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER

Get alerted when new SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER trials appear

New heart valve offers hope for patients with severe leaky heart